First, the work of Duits et al. [78], illustrating high levels of CgA, SgII and VGF in CSF of patients with mild cognitive impairment progressing to AD, suggests that early events in the AD pathophysiological cascade can display opposite changes in DCV cargos in later stages. Here, SCG2 is linked to Alzheimer disease.